Thermo Fisher Scientific Inc. achieved a remarkable first-quarter 2022, reporting an adjusted EPS of $7.25, which exceeded the Zacks Consensus Estimate by 17.5%, alongside revenues of $11.82 billion, a 19% increase year-over-year. The growth was driven by a core organic revenue increase of 16% and significant contributions from acquisitions, which accounted for 18% of total revenue. Despite a reduction in cash reserves to $2.75 billion, the company raised its full-year guidance and announced a dividend increase, signaling robust financial health.
“Thermo Fisher Scientific Inc. · first-quarter 2022 adjusted earnings per share (EPS) · $7.25 · beat the Zacks Consensus Estimate by 17.5%”
“Thermo Fisher Scientific Inc. · GAAP EPS · $5.61 · reflecting a 4.6% rise on a year-over-year basis”
“Thermo Fisher Scientific Inc. · revenues in the quarter · $11.82 billion · up 19% year over year”
“Thermo Fisher Scientific Inc. · top line · $11.82 billion · exceeded the Zacks Consensus Estimate by 11.2%”
“Thermo Fisher Scientific Inc. · Organic revenues in the reported quarter · 3% · year over year”
“Thermo Fisher Scientific Inc. · currency translation · lowered revenues · by 2%”
“Thermo Fisher Scientific Inc. · Acquisitions · contributed 18% · to the top line”
“Thermo Fisher Scientific Inc. · core organic revenue growth · 16% · considering the impact of PPD revenue”
“Thermo Fisher · exited the first quarter with cash and cash equivalents · $2.75 billion · compared with $4.48 billion at the end of 2021”
“Thermo Fisher · has a consistent dividend-paying history · five-year annualized dividend growth · 14.9%”
“Thermo Fisher Scientific · expected first-quarter revenue · $10.63 billion”
“Thermo Fisher Scientific · expected decline in earnings per share · 14.4% · from year-ago quarter”